Immune Activation Effects at Different Irradiated Sites and Optimal Timing of Radioimmunotherapy in Patients with Extensive-Stage Small Cell Lung Cancer: a Real-World Analysis.

Biol Proced Online · 2023 · PMC10503112 · PMID 37710179

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, in our real-world analysis, RT combined with immunotherapy showed a trend of survival improvement in first-line RIT regardless of the irradiated site, and patients who received RIT earlier achieved higher survival rates.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.